<DOC>
	<DOCNO>NCT01276054</DOCNO>
	<brief_summary>Lymph node biopsy follow axillary reverse mapping may reduce incidence severity arm lymphedema . This randomized phase II trial study well sentinel and/or axillary lymph node biopsy without axillary reverse mapping work reduce incidence severity lymphedema patient resectable stage 0-II breast cancer</brief_summary>
	<brief_title>Sentinel and/or Axillary Lymph Node Biopsy With Without Axillary Reverse Mapping Reducing Incidence Severity Arm Lymphedema Stage 0-2 Patients .</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate ability axillary reverse mapping ( ARM ) reduce incidence lymphedema ( LE ) follow axillary nodal staging . SECONDARY OBJECTIVES : I . To document use standardize LE screen LE level-specific management protocol outcome LE among patient develop LE . II . To document relationship limb volume measurement assess infrared laser perometry bioelectrical impedance spectroscopy . OUTLINE : Patients randomize 1 2 treatment arm . ARM I : Patients undergo sentinel lymph node biopsy ( SNB ) and/or axillary lymph node biopsy ( ALND ) use technetium Tc 99m sulfur colloid follow methylene blue indocyanine green solution tracer localization arm lymph node . Patients undergo axillary reverse mapping . ARM II : Patients undergo SNB and/or ALND use technetium Tc 99m sulfur colloid follow methylene blue indocyanine green solution tracer localization arm lymph node . After completion study treatment , patient follow 1-2 week , 3 month , every 6 month 4 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>Stage 0 , I , II Breast Cancer Not pregnant breastfeed Breast cancer prophylactic mastectomy require axillary nodal stag Ability read and/or comprehend consent form questionnaires Ability followup per protocol Unilateral axillary staging Stage 3 Previous axillary lymph node dissection Neoadjuvant chemotherapy hormonal therapy exceed great 30 day duration Allergy blue dye iodine ; NOTE : nonblue dye noniodinecontaining dye may use patient Patients implant medical device pacemaker may undergo perometry , BIS ( Bioelectrical Impedance Spectroscopy ) Previous diagnosis LE ( lymphedema ) either extremity Bilateral axillary staging</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>